Used in the synthesis of pharmaceutical intermediates, particularly in the development of selective kinase inhibitors. It serves as a chiral building block in the production of active pharmaceutical ingredients targeting inflammatory diseases and certain cancers. Its fluorinated chromane structure enhances binding affinity and metabolic stability in drug candidates. Commonly employed in research settings for optimizing potency and selectivity in central nervous system-targeted therapies.